Ocular Cicatricial Pemphigoid
6
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
100%
2 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid
Subconjunctival Humira for Boston Keratoprosthesis
Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies
Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
Implantable Intraocular Pressure Sensor for Glaucoma Monitoring in Patients With Boston Keratoprosthesis Type 1
Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation